Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04984837
Title Study of Lacutamab in Peripheral T-cell Lymphoma
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Lymphoma Academic Research Organisation
Indications

peripheral T-cell lymphoma

anaplastic large cell lymphoma

angioimmunoblastic T-cell lymphoma

aggressive NK-cell leukemia

adult T-cell leukemia

Therapies

Gemcitabine + Oxaliplatin

Gemcitabine + Lacutamab + Oxaliplatin

Age Groups: senior | adult
Covered Countries


No variant requirements are available.